ask="1.000"
ask_size="2200"
average_daily_volume="3571"
bid="0.250"
bid_size="100"
book_value="0.000"
change="+0.081"
change_from_200_day_moving_average="-0.328"
change_from_50_day_moving_average="-0.028"
change_from_52_week_high="-1.419"
change_From_52_week_low="0.330"
change_in_percent="+20.310%"
close="0.481"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="0.520"
high_52_weeks="1.900"
last_trade_date="2/6/2017"
last_trade_price="0.481"
last_trade_size="100"
last_trade_time="3:59pm"
low="0.350"
low_52_weeks="0.152"
market_capitalization="N/A"
moving_average_200_day="0.809"
moving_average_50_day="0.509"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="N/A"
open="0.520"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-40.540%"
percent_change_from_50_day_moving_average="-5.562%"
percent_change_from_52_week_high="-74.684%"
percent_change_from_52_week_low="+217.492%"
previous_close="0.400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.000"
stock_exchange="NGM"
symbol="ONSIZ"
volume="1850"
weeks_range_52="0.152 - 1.900"
